Pacira Pharmaceuticals, Inc. (PCRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
36.40+1.70 (+4.90%)
As of 11:32 AM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close34.70
Bid36.00 x 600
Ask36.05 x 500
Day's Range34.25 - 36.40
52wk Range31.08 - 80.25
1y Target EstN/A
Market Cap1.36B
P/E Ratio (ttm)-117.04
Avg Vol (3m)728,295
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube22 hours ago

    Top 5 valuable Pharma stocks : October 24, 2016

    Categories: Yahoo Finance Symbol Company Fundamental Analysis Score One Month Share Price Performance Market Cap (millions) TNPH-US Tian’an Pharmaceutical Co. Ltd. 95 -26 5.18 BSTC-US BioSpecifics Technologies Corp. 89 3.79 318.41 JAZZ-US Jazz Pharmaceuticals Plc 88 -5.86 7340.11 PCRX-US Pacira Pharmaceuticals, Inc. 88 -8.72 1252.54 IGXT-US Intelgenx Technologies Corp. 88 -4.35 47.62 While TNPH-US‘s change in share price ... Read more (Read more...)

  • What Falling Estimates & Price Mean for Pacira Pharmaceuticals (PCRX)

    What Falling Estimates & Price Mean for Pacira Pharmaceuticals (PCRX)

    Pacira Pharmaceuticals (PCRX) has witnessed a significant price decline and negative trend in earnings estimate revisions in the past four weeks

  • GlobeNewswire5 days ago

    Pacira Pharmaceuticals Continues to Build Out Robust Commercial Leadership Team

    PARSIPPANY, N.J., Oct. 20, 2016-- Pacira Pharmaceuticals, Inc. today announced the appointment of two key individuals who will assume leadership roles within the company’ s commercial organization. Thomas ...